https://orcid.org/0000-0003-1890-5409
Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Avantika Singh, Aristides Hadjinicolaou, Jurriaan M Peters & Catherine L Salussolia. (2023) Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions. Neuropsychiatric Disease and Treatment 19, pages 733-748.
Read now
Read now
Gonzalo Astray, Juan C. Mejuto, Jianbo Xiao & Jesus Simal-Gandara. (2023) Benefits, toxicity and current market of cannabidiol in edibles. Critical Reviews in Food Science and Nutrition 63:22, pages 5800-5812.
Read now
Read now
Roberta Roberti, Caterina Palleria, Valentina Nesci, Martina Tallarico, Carlo Di Bonaventura, Emanuele Cerulli Irelli, Alessandra Morano, Giovambattista De Sarro, Emilio Russo & Rita Citraro. (2020) Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 983-995.
Read now
Read now
Articles from other publishers (38)
Carlos A. Lafourcade, Fraser T. Sparks, Angelique Bordey, Ursula Wyneken & Michael H. Mohammadi. (2023)
Cannabinoid regulation of neurons in the dentate gyrus during epileptogenesis: Role of
CB1R
‐associated proteins and downstream pathways
. Epilepsia 64:6, pages 1432-1443.
Crossref
Crossref
Mariana Babayeva & Zvi G. Loewy. (2023) Cannabis Pharmacogenomics: A Path to Personalized Medicine. Current Issues in Molecular Biology 45:4, pages 3479-3514.
Crossref
Crossref
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev & Iain S. McGregor. (2022) The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence. Clinical and Translational Science 16:1, pages 10-30.
Crossref
Crossref
J. Eduardo Rodriguez-Almaraz & Nicholas Butowski. (2023) Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis). Current Treatment Options in Oncology 24:1, pages 30-44.
Crossref
Crossref
Joaquin Guerra, Vinogran Naidoo & Ramon Cacabelos. (2022) Potential effects of cannabinoids on audiovestibular function: A narrative review. Frontiers in Pharmacology 13.
Crossref
Crossref
Gabriele Ruffolo, Alessandro Gaeta, Beatrice Cannata, Camilla Pinzaglia, Eleonora Aronica, Alessandra Morano, Pierangelo Cifelli & Eleonora Palma. (2022) GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol. Life 12:12, pages 2042.
Crossref
Crossref
Eric Witherspoon, Sean Quinlan & Patrick A. Forcelli. (2022) Preclinical efficacy of cannabidiol for the treatment of early-life seizures. Pharmacological Reports 74:5, pages 1092-1098.
Crossref
Crossref
Arvind Kumar, Kayla Kindig, Shanlin Rao, Afroditi-Maria Zaki, Sandip Basak, Mark S. P. Sansom, Philip C. Biggin & Sudha Chakrapani. (2022) Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs. Nature Communications 13:1.
Crossref
Crossref
Muhammad Yousaf, Dennis Chang, Yang Liu, Tianqing Liu & Xian Zhou. (2022) Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders. Molecules 27:15, pages 4961.
Crossref
Crossref
Valentina L. Savchenko. (2021) Modulation of Excitatory Synaptic Transmission During Cannabinoid Receptor Activation. Cellular and Molecular Neurobiology 42:6, pages 1933-1947.
Crossref
Crossref
Ellen N. Hurley, Carolyn J. Ellaway, Alexandra M. Johnson, Linda Truong, Rebecca Gordon, Peter Galettis, Jennifer H. Martin & John A. Lawson. (2022) Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia 63:7, pages 1736-1747.
Crossref
Crossref
Cláudia Carvalho & Maria A. Vieira-Coelho. (2022) Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms. Pharmacological Research 181, pages 106258.
Crossref
Crossref
Amber Salter, Gary Cutter, Ruth Ann Marrie, Kathryn Nichol, Joshua R. Steinerman, Karry M.J. Smith & Robert J. Fox. (2022) Sources of Cannabis Information and Medical Guidance for Neurologic Use. Neurology: Clinical Practice 12:2, pages 102-112.
Crossref
Crossref
Almudena Robledo‐Menendez, Maria Vella, Pedro Grandes & Edgar Soria‐Gomez. (2021)
Cannabinoid control of hippocampal functions: the
where
matters
. The FEBS Journal 289:8, pages 2162-2175.
Crossref
Crossref
Mengya Wang, Huayuan Liu & Zegang Ma. (2022) Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care
41
89
.
Andy Sivils, John Q. Wang & Xiang-Ping Chu. (2021) Striatonigrostriatal Spirals in Addiction. Frontiers in Neural Circuits 15.
Crossref
Crossref
Jon Egaña-Huguet, Edgar Soria-Gómez & Pedro Grandes. (2021) The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. International Journal of Molecular Sciences 22:24, pages 13231.
Crossref
Crossref
Margaret-Ann Tait, Daniel S J Costa, Rachel Campbell, Richard Norman, Stephan Schug & Claudia Rutherford. (2021) A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study. JMIR Research Protocols 10:11, pages e32327.
Crossref
Crossref
M. Bou Nasif, M. Koubeissi & N.J. Azar. (2021) Epilepsy – from mysticism to science. Revue Neurologique 177:9, pages 1047-1058.
Crossref
Crossref
Daniel Zhou, Erin Dennis, Isha Snehal & Arun Swaminathan. (2021) Cannabinoids in the Treatment of Epilepsy: A Review. European Medical Journal.
Crossref
Crossref
Erica Zamberletti, Tiziana Rubino & Daniela Parolaro. (2021) Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacology & Therapeutics 226, pages 107878.
Crossref
Crossref
Aaron M. Farrelly, Styliani Vlachou & Konstantinos Grintzalis. (2021) Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances. International Journal of Environmental Research and Public Health 18:8, pages 3993.
Crossref
Crossref
Milan Grundmann & Ivana Kacířová. (2021) Pharmacokinetic and pharmacodynamic interactions of antiepileptic drugs. Klinická farmakologie a farmacie 35:1, pages 12-18.
Crossref
Crossref
Pierangelo Cifelli, Silvia Di Angelantonio, Veronica Alfano, Alessandra Morano, Eleonora De Felice, Eleonora Aronica, Gabriele Ruffolo & Eleonora Palma. (2021) Dissecting the Molecular Determinants of GABAA Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy. Brain Sciences 11:4, pages 441.
Crossref
Crossref
Carmen Navarrete, Adela García-Martín, Alain Rolland, Jim DeMesa & Eduardo Muñoz. (2021) Cannabidiol and Other Cannabinoids in Demyelinating Diseases. International Journal of Molecular Sciences 22:6, pages 2992.
Crossref
Crossref
Michael T.M. Wang & Helen V. Danesh-Meyer. (2021) Cannabinoids and the eye. Survey of Ophthalmology 66:2, pages 327-345.
Crossref
Crossref
Valentina Franco, Meir Bialer & Emilio Perucca. (2021) Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research. Neuropharmacology 185, pages 108442.
Crossref
Crossref
Valentina Satta, Cristina Alonso, Paula Díez, Soraya Martín-Suárez, Marta Rubio, Juan M. Encinas, Javier Fernández-Ruiz & Onintza Sagredo. (2021) Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Taiana Maia de Oliveira, Lotte van Beek, Fiona Shilliday, Judit É. Debreczeni & Chris Phillips. (2021) Cryo-EM: The Resolution Revolution and Drug Discovery. SLAS Discovery 26:1, pages 17-31.
Crossref
Crossref
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez & Ilhuicamina Daniel Limón. (2020) Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease. Frontiers in Pharmacology 11.
Crossref
Crossref
Claire M. Williams & Gary J. Stephens. (2020) Development of cannabidiol as a treatment for severe childhood epilepsies. British Journal of Pharmacology 177:24, pages 5509-5517.
Crossref
Crossref
Vanessa L. Breton, Suzie Dufour, Yotin Chinvarun, Jose Martin Del Campo, Berj L. Bardakjian & Peter L. Carlen. (2020) Transitions between neocortical seizure and non-seizure-like states and their association with presynaptic glutamate release. Neurobiology of Disease 146, pages 105124.
Crossref
Crossref
Engin YÜCEL, Zühal AKTUNA & İsmail Semih KESKİL. (2020) Effects of endocannabinoids in pentylenetetrazole induced seizures in miceFarelerde pentilentetrazol ile oluşturulan epilepsiye endokannabinoidlerin etkisi. Acta Medica Alanya 4:3, pages 209-215.
Crossref
Crossref
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England & Saoirse E. O'Sullivan. (2020) A systematic review of minor phytocannabinoids with promising neuroprotective potential. British Journal of Pharmacology 177:19, pages 4330-4352.
Crossref
Crossref
Luis Felipe Santos Menezes, Elias Ferreira Sabiá Júnior, Diogo Vieira Tibery, Lilian dos Anjos Carneiro & Elisabeth Ferroni Schwartz. (2020) Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review. Frontiers in Pharmacology 11.
Crossref
Crossref
Merrill Norton. (2020) To CBD or not to CBD?: What pharmacists need to know. Pharmacy Today 26:8, pages 41-55.
Crossref
Crossref
Patrícia Alves, Cristina Amaral, Natércia Teixeira & Georgina Correia-da-Silva. (2020) Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol. Pharmacological Research 157, pages 104822.
Crossref
Crossref